We are live on ! Find out more
LENZ

LENZ Therapeutics
LENZ

67 hedge funds and large institutions have $75.8M invested in LENZ Therapeutics in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

2% more funds holding

Funds holding: 66 → 67 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.15% less ownership

Funds ownership: 7.68% → 7.53% (-0.15%)

7% less capital invested

Capital invested by funds: $81.2M → $75.8M (-$5.47M)

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
22
Reduced
17
Closed
11
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
+$1.35M
2
BlackRock
BlackRock
New York
+$235K
3
Morgan Stanley
Morgan Stanley
New York
+$184K
4
Millennium Management
Millennium Management
New York
+$147K
5
CCM
Corsair Capital Management
New York
+$114K

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$1.06M
2
PM
Prosight Management
Texas
-$900K
3
Verition Fund Management
Verition Fund Management
Connecticut
-$596K
4
CAM
Cormorant Asset Management
Massachusetts
-$519K
5
WSL
Western Standard LLC
California
-$455K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$15.3K -$7.81K -449 -34%
TRCT
52
Tower Research Capital (TRC)
New York
$11K +$3.1K +178 +39%
Nisa Investment Advisors
53
Nisa Investment Advisors
Missouri
$10.7K +$10.7K +616 New
AB
54
Amalgamated Bank
New York
$7K – – –
Lazard Asset Management
55
Lazard Asset Management
New York
$7K +$365 +21 +5%
Legal & General Group
56
Legal & General Group
United Kingdom
$6.64K – – –
Osaic Holdings
57
Osaic Holdings
Arizona
$6.6K +$3.29K +189 +99%
AIP
58
Ameritas Investment Partners
Nebraska
$5.74K – – –
CUAMC
59
China Universal Asset Management Company
China
$3.68K +$1.79K +103 +94%
NA
60
Nordwand Advisors
Pennsylvania
$2.48K – – –
Fidelity Investments
61
Fidelity Investments
Massachusetts
$1.99K -$1.24K -71 -38%
Citigroup
62
Citigroup
New York
$1.82K -$21.4K -1,228 -92%
RTL
63
Red Tortoise LLC
Georgia
$1.58K +$1.58K +91 New
EWA
64
EverSource Wealth Advisors
Alabama
$593 +$591 +34 New
FDCDDQ
65
Federation des caisses Desjardins du Quebec
Quebec, Canada
$496 – – –
Federated Hermes
66
Federated Hermes
Pennsylvania
– -$1.06M -58,308 Closed
Verition Fund Management
67
Verition Fund Management
Connecticut
– -$596K -32,750 Closed
CAM
68
Cormorant Asset Management
Massachusetts
– -$519K -28,507 Closed
WSL
69
Western Standard LLC
California
– -$455K -25,012 Closed
BCM
70
BML Capital Management
Indiana
– -$396K -21,756 Closed
DC
71
Diametric Capital
Massachusetts
– -$94.4K -5,186 Closed
AC
72
Annandale Capital
Texas
– -$47K -2,561 Closed
LCM
73
Laurion Capital Management
New York
– -$31.7K -1,743 Closed
EAM
74
Erste Asset Management
Austria
– -$30.8K -1,700 Closed
SOW
75
State of Wyoming
Wyoming
– -$663 -36 Closed
1 2
3
4

LENZ Hedge Fund Activity: Q3 2023 in Review

67 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q3 2023, worth a combined $75.8M — down 6.7% from $81.2M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LENZ positions and 11 closed out — a net gain of 1 holder — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Newtyn Management, opening a new position worth an estimated $1.35M. The largest seller was Federated Hermes, exiting entirely with an estimated $1.06M sold.

  • 67 institutional investors held LENZ Therapeutics (LENZ) as of Q3 2023, up from 66 in Q2 2023.
  • Funds reported $75.8M of LENZ Therapeutics stock for Q3 2023, down 6.7% quarter-over-quarter.
  • 12 funds opened new LENZ Therapeutics positions in Q3 2023 and 11 closed out, a net change of +1 holder.
  • The largest LENZ Therapeutics buyer in Q3 2023 was Newtyn Management, an estimated $1.35M added.
  • The largest LENZ Therapeutics seller in Q3 2023 was Federated Hermes, an estimated $1.06M sold.

Based on aggregated 13F filings for Q3 2023.